Table 3: The number of comorbidities for the patients in the BIO cohort identified from each data source demonstrates the importance of including both.
Data source | Number of comorbidities identified from each source | Number of patients identified from each source |
---|---|---|
WLGP data only | 810 | 253 |
PEDW data only | 704 | 167 |
Present in both | 66 |